Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

ClinicalTrials.gov ID: NCT01817075

Public ClinicalTrials.gov record NCT01817075. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Impact of Cleansing With Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children With Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized phase III trial studies chlorhexidine gluconate cleansing to see how well it works compared to control cleansing in preventing central line associated bloodstream infection and acquisition of multi-drug resistant organisms in younger patients with cancer or undergoing donor stem cell transplant. Chlorhexidine gluconate may help reduce bloodstream infections and bacterial infections associated with the central line.

Study identification

NCT ID
NCT01817075
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Children's Oncology Group
Network
Enrollment
177 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Months to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 4, 2013 (Actual)
Primary completion
Mar 31, 2019 (Actual)
Completion
Mar 31, 2020 (Actual)
Last update posted
Jun 22, 2021

2013 – 2020

United States locations

U.S. sites
53
U.S. states
24
U.S. cities
47
Facility City State ZIP Site status
City of Hope Comprehensive Cancer Center Duarte California 91010 —
Miller Children's and Women's Hospital Long Beach Long Beach California 90806 —
Children's Hospital Los Angeles Los Angeles California 90027 —
Valley Children's Hospital Madera California 93636 —
Children's Hospital and Research Center at Oakland Oakland California 94609-1809 —
Children's Hospital of Orange County Orange California 92868 —
UCSF Medical Center-Parnassus San Francisco California 94143 —
UCSF Medical Center-Mission Bay San Francisco California 94158 —
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance California 90502 —
Connecticut Children's Medical Center Hartford Connecticut 06106 —
Yale University New Haven Connecticut 06520 —
Alfred I duPont Hospital for Children Wilmington Delaware 19803 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Nemours Children's Clinic-Jacksonville Jacksonville Florida 32207 —
Nemours Children's Hospital Orlando Florida 32827 —
Nemours Children's Clinic - Pensacola Pensacola Florida 32504 —
Johns Hopkins All Children's Hospital St. Petersburg Florida 33701 —
Tampa General Hospital Tampa Florida 33606 —
Children's Healthcare of Atlanta - Egleston Atlanta Georgia 30322 —
University of Illinois Chicago Illinois 60612 —
Children's Hospital New Orleans New Orleans Louisiana 70118 —
Ochsner Medical Center Jefferson New Orleans Louisiana 70121 —
Eastern Maine Medical Center Bangor Maine 04401 —
Sinai Hospital of Baltimore Baltimore Maryland 21215 —
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 —
Dana-Farber Cancer Institute Boston Massachusetts 02215 —
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201 —
Children's Mercy Hospitals and Clinics Kansas City Missouri 64108 —
Washington University School of Medicine St Louis Missouri 63110 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
The Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park New York 11040 —
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032 —
Montefiore Medical Center - Moses Campus The Bronx New York 10467 —
New York Medical College Valhalla New York 10595 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
The Toledo Hospital/Toledo Children's Hospital Toledo Ohio 43606 —
Legacy Emanuel Children's Hospital Portland Oregon 97227 —
Oregon Health and Science University Portland Oregon 97239 —
Sanford USD Medical Center - Sioux Falls Sioux Falls South Dakota 57117-5134 —
T C Thompson Children's Hospital Chattanooga Tennessee 37403 —
St. Jude Children's Research Hospital Memphis Tennessee 38105 —
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 —
Dell Children's Medical Center of Central Texas Austin Texas 78723 —
Driscoll Children's Hospital Corpus Christi Texas 78411 —
Cook Children's Medical Center Fort Worth Texas 76104 —
Children's Hospital of San Antonio San Antonio Texas 78207 —
Methodist Children's Hospital of South Texas San Antonio Texas 78229 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 —
Virginia Commonwealth University/Massey Cancer Center Richmond Virginia 23298 —
Seattle Children's Hospital Seattle Washington 98105 —
Providence Sacred Heart Medical Center and Children's Hospital Spokane Washington 99204 —
Madigan Army Medical Center Tacoma Washington 98431 —
Saint Vincent Hospital Cancer Center Green Bay Green Bay Wisconsin 54301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01817075, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2021 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01817075 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →